Kenar D. Jhaveri
A5018399640- Renal Diseases and Glomerulopathies
- Renal Transplantation Outcomes and Treatments
- Cancer Immunotherapy and Biomarkers
- Chronic Kidney Disease and Diabetes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Renal cell carcinoma treatment
- Complement system in diseases
- COVID-19 Clinical Research Studies
- Dialysis and Renal Disease Management
- Chronic Lymphocytic Leukemia Research
- Electrolyte and hormonal disorders
- Vasculitis and related conditions
- Muscle and Compartmental Disorders
- Potassium and Related Disorders
- Social Media in Health Education
- Chronic Myeloid Leukemia Treatments
- Polyomavirus and related diseases
- Acute Kidney Injury Research
- Innovations in Medical Education
- Healthcare cost, quality, practices
- Multiple Myeloma Research and Treatments
- Autoimmune Bullous Skin Diseases
- Diversity and Career in Medicine
- Neurological Complications and Syndromes
- Hemoglobinopathies and Related Disorders
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2018-2025
Northwell Health
2014-2025
Hofstra University
2016-2025
St. Vincent's University Hospital
2025
University College Dublin
2025
Colorado Kidney Care
2017-2024
Feinstein Institute for Medical Research
2024
Long Island Jewish Medical Center
2012-2023
North Shore University Hospital
2012-2023
RELX Group (United States)
2017-2020
The rate of acute kidney injury (AKI) associated with patients hospitalized Covid-19, and outcomes are not well understood. This study describes the presentation, risk factors AKI in Covid-19. We reviewed health records for all Covid-19 between March 1, April 5, 2020, at 13 academic community hospitals metropolitan New York. Patients younger than 18 years age, end stage disease or a transplant were excluded. was defined according to KDIGO criteria. Of 5,449 admitted developed 1,993 (36.6%)....
Significance Statement AKI is a known complication of severe COVID-19. Autopsy series patients who died with COVID-19 reported acute tubular necrosis in the kidney, and few patient reports noted presence collapsing glomerulopathy The authors describe clinical kidney histopathologic findings for ten hospitalized underwent biopsy. All had proteinuria, eight required dialysis. Biopsy samples showed varying degrees all patients; one also associated myoglobin cast nephropathy. Pathologic analysis...
Outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19) and acute kidney injury (AKI) are not well understood. The goal this study was to investigate the survival outcomes these patients.Retrospective cohort study.Patients (aged≥18 years) COVID-19 at 13 hospitals in metropolitan New York between March 1, 2020, April 27, followed up until hospital discharge.AKI.Primary outcome: in-hospital death.requiring dialysis discharge, recovery function.Univariable multivariable...
Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has emerged as an important toxicity among patients with cancer. Methods We collected data on 429 ICPi-AKI and control who received ICPis contemporaneously but did not develop from 30 sites in 10 countries. Multivariable logistic regression was used to identify predictors of its recovery. A multivariable Cox model estimate the effect ICPi rechallenge versus no survival following ICPi-AKI. Results occurred at a...
Coronavirus disease 2019 (COVID-19) is a pandemic caused by novel coronavirus that has been identified to belong the β-coronavirus family.1 As COVID-19 continues evolve, more aspects of this illness are being defined and described. In United States, incidence acute kidney injury (AKI) in patients hospitalized with reported be around 37%.2 Different autopsy biopsy series have revealed tubular (ATI) most common renal pathology lesion these patients.
In kidney transplant recipients, cancer is one of the leading causes death with a functioning graft beyond first year transplantation, and malignancies account for 8-10% all deaths in USA (2.6 deaths/1000 patient-years) exceed 30% Australia (5/1000 recipients. Patient-, transplant- medication-related factors contribute to increased risk following transplantation. While it well established that overall immunosuppressive dose associated an contributive effect different agents not established....
This study describes the incidence, associated clinical characteristics and outcomes of acute kidney injury in a pediatric cohort with COVID-19 Multisystem Inflammatory Syndrome Children (MIS-C). We performed retrospective patients 18 years age under admitted to four New York hospitals Northwell Health System interned during height pandemic, between March 9 August 13, 2020. Acute was defined staged according Kidney Disease: Improving Global Outcomes criteria. The included 152 patients; 97...
IntroductionPost-marketing data on outcomes of avacopan use in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) are lacking.MethodsWe performed a multi-center retrospective analysis 92 patients with newly diagnosed or relapsing AAV who received therapy avacopan. The co-primary outcome measures were clinical remission at 26 and 52 weeks.. We descriptive statistics univariate logistic regression to assess predictors remission, respectively.ResultsOf the patients, 21 (23%)...
To develop and externally validate a prediction model for severe cisplatin associated acute kidney injury (CP-AKI).
A) To characterize the incidence of kidney failure associated with intravitreal anti-vascular endothelial growth factor (VEGF) exposure, and B) compare risk in patients treated ranibizumab, aflibercept, or bevacizumab. Retrospective cohort study across 12 databases Observational Health Data Sciences Informatics (OHDSI) network. Subjects aged ≥18 years ≥3 monthly anti-VEGF medications for a blinding disease (diabetic retinopathy, diabetic macular edema, exudative age-related degeneration,...